Research graph
References from Prostate Cancer Mortality in Men not Attending a Population-based Screening Program: The ‘Good’, the ‘Bad’, and the ‘Ugly’ After 20-yr Follow-up in the European Randomised study of Screening for Prostate Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
The Lancet Commission on prostate cancer: planning for the surge in cases
10.1016/s0140-6736(24)00651-2 · 2024 · External reference
Screening and prostate-cancer mortality in a randomized European study
10.1056/nejmoa0810084 · 2009 · External reference
European study of prostate cancer screening - 23-year follow-up
10.1056/nejmoa2503223 · 2025 · External reference
Prostate cancer early detection in the European Union and UK
10.1016/j.eururo.2024.07.019 · 2025 · External reference
Unresolved reference
External reference
Early detection of prostate cancer in the European Union: combining forces with PRAISE-U
10.1016/j.eururo.2023.08.002 · 2023 · External reference
Unresolved reference
External reference
Prostate cancer screening with PSA, kallikrein panel, and MRI: the ProScreen randomized trial
10.1001/jama.2024.3841 · 2024 · External reference
The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate
10.1080/21681805.2021.1881612 · 2021 · External reference
Population-based organised prostate cancer testing: results from the first invitation of 50-year-old men
10.1016/j.eururo.2023.11.013 · 2024 · External reference
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial
10.1016/s1470-2045(21)00348-x · 2021 · External reference
A randomized trial of risk-adapted screening for prostate cancer in young men-Results of the first screening round of the PROBASE trial
10.1002/ijc.33940 · 2022 · External reference
Unresolved reference
External reference
First mammography screening participation and breast cancer incidence and mortality in the subsequent 25 years: population based cohort study
10.1136/bmj-2025-085029 · 2025 · External reference
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
10.1016/s0140-6736(14)60525-0 · 2014 · External reference
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
10.1016/j.eururo.2019.02.009 · 2019 · External reference
Determining the cause of death in randomized screening trial(s) for prostate cancer
10.1111/j.1465-5101.2003.04402.x · 2003 · External reference
Assessment of causes of death in a prostate cancer screening trial
10.1002/ijc.23126 · 2008 · External reference
Prostate cancer and socioeconomic status in the Finnish randomized study of screening for prostate cancer
10.1093/aje/kww084 · 2016 · External reference
Eighteen-year follow-up of the Goteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality
10.1080/21681805.2017.1411392 · 2018 · External reference
Why do men refuse or attend population-based screening for prostate cancer?
10.1093/pubmed/22.3.312 · 2000 · External reference
Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendees
10.1002/cncr.24680 · 2009 · External reference
Why do men opt out of prostate-cancer screening? Attitudes and perception among participants and non-participants of a screening trial
10.1111/j.1464-410x.2010.09165.x · 2010 · External reference
Psychosocial determinants of socioeconomic inequalities in cancer screening participation: a conceptual framework
10.1093/epirev/mxq018 · 2011 · External reference
Determinants of non-participation in population-based breast cancer screening: a systematic review and meta-analysis
2022 · External reference
Factors promoting breast, cervical and colorectal cancer screenings participation: a systematic review
10.1002/pon.5997 · 2022 · External reference
Inequalities and risk factors related to non-participation in colorectal cancer screening programmes: a systematic review
10.1093/eurpub/ckaa203 · 2021 · External reference
Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity
10.2340/1651-226x.2025.43399 · 2025 · External reference
Association of nonadherence to cancer screening examinations with mortality from unrelated causes: a secondary analysis of the PLCO cancer screening trial
10.1001/jamainternmed.2018.5982 · 2019 · External reference
Social determinants of health and US cancer screening interventions: a systematic review
2023 · External reference
Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program
10.1093/ije/dyq003 · 2010 · External reference
Does an organised screening programme reduce the inequalities in breast cancer survival?
10.1093/annonc/mdr121 · 2012 · External reference
Associations between socioeconomic factors and PSA testing in a population-based organised testing programme and routine healthcare: a register-based study of 50-year-old men
2024 · External reference
Associations between neighbourhood characteristics and participation in a population-based organised prostate cancer testing (OPT) programme: a register-based study of 50-year-old men
10.1371/journal.pone.0322643 · 2025 · External reference
The impact of interventions to improve attendance in female cancer screening among lower socioeconomic groups: a review
10.1016/j.ypmed.2010.01.007 · 2010 · External reference
Effect of the correction for noncompliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section Rotterdam)
10.1002/ijc.25278 · 2010 · External reference
Estimate of opportunistic prostate specific antigen testing in the Finnish randomized study of screening for prostate cancer
10.1016/j.juro.2017.01.048 · 2017 · External reference
Contamination by opportunistic screening in the European randomized study of prostate cancer screening
10.1111/j.1464-410x.2003.04407.x · 2003 · External reference
Prostate specific antigen and biopsy contamination in the Göteborg-1 randomized, population-based, prostate cancer screening trial
10.1097/ju.0000000000002835 · 2022 · External reference
Adjusting for non-compliance and contamination in randomized clinical trials
10.1002/(sici)1097-0258(19970515)16:9<1017::aid-sim508>3.0.co;2-v · 1997 · External reference
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
10.1016/j.eururo.2009.07.018 · 2009 · External reference
Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer
10.1016/j.eururo.2013.08.005 · 2014 · External reference
Bias-corrected estimates of effects of PSA screening decisions on the risk of prostate cancer diagnosis and death: analysis of the Finnish randomized study of screening for prostate cancer
10.1002/ijc.32129 · 2019 · External reference
The Finnish prostate cancer screening trial: analyses on the screening failures
10.1002/ijc.29300 · 2015 · External reference
Interventions targeted at women to encourage the uptake of cervical screening
2021 · External reference
Efficacy of interventions intended to increase lung cancer screening rates: a systematic review and meta-analysis
10.1007/s11606-024-09097-8 · 2025 · External reference
Advancing mammographic screening among underserved groups: a systematic review and meta-analysis of intervention strategies to increase breast cancer screening uptake
10.3389/phrs.2025.1607873 · 2025 · External reference
